Nanning

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lung cancer

Running trials

• Active, not recruiting

  Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)

  NCT05607550· Phase 3· ArriVent BioPharma, Inc.· Source